Daiichi Sankyo to supply omicron XBB.1.5-adapted COVID-19 vaccine in Japan

COVID19 |  News | 0 Comment | 22 Nov, 2023

Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to supply the o...Read more

New study in Singapore highlights need for refreshed vaccination strategies

COVID19 |  News | 0 Comment | 25 Aug, 2023

Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...Read more

Singapore develops antibodies to potentially prevent future coronavirus outbreaks

COVID19 |  News | 0 Comment | 31 Jul, 2023

Exceptionally potent antibodies that can neutralise virtually all known variants of the COVID-19 virus—including O...Read more

CSPC Pharma partners with Pfizer for oral COVID-19 treatment in China

COVID19 |  News | 0 Comment | 03 Jul, 2023

CSPC Pharmaceutical Group has signed a strategic partnership agreement with American pharma firm Pfizer to la...Read more

Korea's SK bioscience receives WHO Emergency Use Listing of COVID-19 vaccine

COVID19 |  News | 0 Comment | 20 Jun, 2023

South Korea-based SK bioscience has received the World Health Organisation (WHO) Emergency Use Listing (EUL) of its COVI...Read more

COVID-19 can cause brain cells to ‘fuse’: Australian study

COVID19 |  News | 0 Comment | 14 Jun, 2023

Researchers at The University of Queensland (UQ) in Australia have discovered viruses such as SARS-CoV-2 can cause brain...Read more

SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

COVID19 |  News | 0 Comment | 31 May, 2023

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...Read more

Survey: One-third of COVID-19 vulnerable groups avoid booster shots

COVID19 |  Company results | 0 Comment | 25 Apr, 2023

The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...Read more

Taiwan approves Japan-based Chugai Pharma's drug for COVID-19 treatment

COVID19 |  News | 0 Comment | 26 Apr, 2023

Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Japan's Chugai Pharmaceutical, has obtained an import drug licen...Read more

Australian government injects $50 M more for research into long COVID

COVID19 |  News | 0 Comment | 24 Apr, 2023

The Australian Government will provide a further $50 million from the Medical Research Future Fund (MRFF) for research i...Read more

Taiwan expands eligibility for using Moderna's COVID-19 vaccine as booster for children

COVID19 |  News | 0 Comment | 17 Apr, 2023

The Central Epidemic Command Center (CECC) in Taiwan has reported that the Advisory Committee on Immunisation Practices ...Read more

NZ-based diagnostic startup Pictor raises $5 M for product development

COVID19 |  News | 0 Comment | 06 Dec, 2022

New Zealand (NZ)-based startup Pictor, with operations in US and India, has announced a funding round to help accelerate...Read more

CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai

COVID19 |  News | 0 Comment | 01 Nov, 2022

CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...Read more

Singapore authorises Pfizer's COVID-19 vaccine for kids

COVID19 |  News | 0 Comment | 30 Sep, 2022

The Health Sciences Authority (HSA) has authorised Pfizer’s Comirnaty COVID-19 vaccine on 28 September 2022, for t...Read more

China's BGI donates Huo-Yan Air Laboratory to Thailand

COVID19 |  News | 0 Comment | 20 Sep, 2022

On September 19, 2022, Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, Dr Satit Pitutecha, Dep...Read more

Australia identifies unique biomarkers of SARS-CoV-2 acute infections, Long COVID

COVID19 |  News | 0 Comment | 21 Sep, 2022

Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quanti...Read more

Singapore grants interim authorisation for first bivalent COVID-19 booster vaccine

COVID19 |  News | 0 Comment | 14 Sep, 2022

Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...Read more

Australia to focus research on five virus families likely to cause future pandemics

COVID19 |  News | 0 Comment | 30 Aug, 2022

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...Read more